SCHEMBL4809657

SCHEMBL4809657

CC(C(=O)O)c1ccoc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.40
PTGS1 P23219 8/20 0.39
CXCL8 P10145 3/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
MMP16 P51512 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
PTPN1 P18031 1/20 0.37
PTPN7 P35236 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
ESR2 Q92731 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4810662 1.00 PTGS2 (0.40) PTGS2PTGS1CXCL8MMP1MMP2
Trifluoroacetic Acid SCHEMBL5414880 0.90 PTGS2 (0.37) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL15018198 0.74
SCHEMBL18610686 0.74
SCHEMBL18640601 0.73 PTGS2 (0.39) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL7250159 0.73 CXCL8 (0.41) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL5215577 0.72 PTGS2 (0.52) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL59839 0.72 PTGS2 (0.52) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL288752 0.72 PTGS2 (0.52) PTGS2PTGS1CXCL8MMP1MMP2
SCHEMBL30338418 0.72 PTGS2 (0.52) PTGS2PTGS1CXCL8MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7335516-B2 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. (US) 2008-02-26 US disclosed
US-7303750-B2 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. (US) 2007-12-04 US disclosed
US-7147858-B2 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. (US) 2006-12-12 US disclosed